The above is a Report of a German Study--maybe they did not receive the memo stating the patches were defective? Maybe it doesn't really matter in RLS if one receives the dopamine agonist or not? Maybe the study was completed before the recall and is now just being reported? Maybe the patches work in Germany but not in the USA? Maybe the patches are defective but have not been recalled in Germany because their equivalent of the FDA is ignoring the problem? Maybe defective rotigitine patches work in RLS but not PD? Maybe RLS is so over diagnosed, most individuals do not really require therapy? (medicalizing a symptom to induce purchasing a pharmaceutical agent--Oh who would do that?)
So many questions. We still have a "starter box' of rotigitine patches. (For any individual who has real RLS, my apologies for the next statement: Might save them in case I develop RLS...madelyn